Apyx Medical Corporation (NASDAQ: APYX - Get Free Report) has been assigned a consensus rating of "M

Apyx Medical Corporation (APYX) Q2 2026 Earnings Call Transcript

Apyx Medical NASDAQ: APYX reported second-quarter revenue growth of 22% as sales in its surgical aes

Apyx Medical (NASDAQ:APYX) reported quarterly losses of $(0.07) per share which beat the analyst con

Apyx Medical (NASDAQ:APYX) affirms FY2026 sales outlook from $59.000 million-$60.000 million to $59.

CLEARWATER, Fla., Aug. 06, 2026 (GLOBE NEWSWIRE) -- Apyx Medical Corporation (NASDAQ:APYX) (“Apyx Me

CLEARWATER, Fla., July 28, 2026 (GLOBE NEWSWIRE) -- Apyx Medical Corporation (NASDAQ:APYX) (“Apyx Me

CLEARWATER, Fla., July 23, 2026 (GLOBE NEWSWIRE) -- Apyx Medical Corporation (NASDAQ:APYX) (the “Com

Wall Street analysts changed outlook on top stocks. To see all changes, visit the analyst ratings pa

HC Wainwright & Co. analyst Yi Chen initiates coverage on Apyx Medical (NASDAQ:APYX) with a B

https://www.sec.gov/ix?doc=/Archives/edgar/data/719135/000149315226029081/form8-k.htm

CLEARWATER, Fla., May 27, 2026 /PRNewswire/ -- Apyx Medical Corporation (NASDAQ:APYX) ("Apyx Medical

In this study, 22 patients received a single treatment session combining these modalities to address

Published data demonstrates visible reduction in dimpling and progressive tissue remodeling through

The study evaluated patient-reported outcomes following liposuction with and without helium plasma r

CLEARWATER, Fla., May 14, 2026 (GLOBE NEWSWIRE) -- Apyx Medical Corporation (NASDAQ:APYX) (the “Comp

Addition of the power liposuction capability as a second advanced liposuction modality is expected t

Apyx Medical Corporation (APYX) Q1 2026 Earnings Call Transcript

Apyx Medical (APYX) came out with a quarterly loss of $0.05 per share versus the Zacks Consensus Est

Apyx Medical (NASDAQ:APYX) raises FY2026 sales outlook from $57.500 million-$58.500 million to $59.0

Apyx Medical (NASDAQ:APYX) reported quarterly losses of $(0.05) per share which beat the analyst con

CLEARWATER, Fla., May 07, 2026 (GLOBE NEWSWIRE) -- Apyx Medical Corporation (NASDAQ:APYX) (“Apyx Med

CLEARWATER, Fla., April 23, 2026 (GLOBE NEWSWIRE) -- Apyx Medical Corporation (NASDAQ:APYX) (the “Co

Renuvion continues to lead in minimally invasive body contouring as the trusted solution for loose s

Craig-Hallum analyst Matthew Hewitt maintains Apyx Medical (NASDAQ:APYX) with a Buy and raises th

Wall Street analysts upgraded Uniqure NV, Apyx Medical Inc, J M Smucker Co, and VTEX with raised pri

Apyx Medical Corporation (APYX) Q4 2025 Earnings Call Transcript

Apyx Medical (NASDAQ:APYX) sees FY2026 sales of $57.500 million-$58.500 million vs $55.480 million a

Apyx Medical (NASDAQ:APYX) reported quarterly losses of $(0.03) per share which beat the analyst con

CLEARWATER, Fla., March 10, 2026 (GLOBE NEWSWIRE) -- Apyx Medical Corporation (NASDAQ:APYX) (“Apyx M

CLEARWATER, Fla., Feb. 18, 2026 (GLOBE NEWSWIRE) -- Apyx Medical Corporation (NASDAQ:APYX) (the “Com

Overview of the Recent Transaction On December 31, 2025, Chuck Royce (Trades, Portfolio), a renowned

CLEARWATER, Fla., Jan. 12, 2026 (GLOBE NEWSWIRE) -- Apyx Medical Corporation (Nasdaq: APYX) (the “Co

Roth Capital analyst Kyle Bauser initiates coverage on Apyx Medical (NASDAQ:APYX) with a Buy rati

Apyx Medical Corporation (NASDAQ:APYX) (the "Company" or "Apyx Medical") the leader

Apyx Medical Corporation (NASDAQ:APYX) (the "Company" or "Apyx Medical") the leader

Citizens analyst David Turkaly upgrades Apyx Medical (NASDAQ:APYX) from Market Perform to Market

Apyx Medical (NASDAQ:APYX) raises FY2025 sales outlook from $50.000 million-$52.000 million to $50.5

Apyx Medical (NASDAQ:APYX) reported quarterly losses of $(0.05) per share which beat the analyst con

Initiated Nationwide Commercial Launch of AYON in SeptemberThe Company is Hosting a Virtual Key Opin